- Conditions
- Asymptomatic Carotid Artery Stenosis, Carotid Artery Atheroma, Carotid Atherosclerosis
- Interventions
- 64Cu-25%-CANF-Comb
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 2
- States / cities
- Los Angeles, California • St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Mar 22, 2026 · Synced May 19, 2026, 7:42 PM EDT